Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
December 20, 2013 DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

View HTML
April 21, 2011 D/A View HTML
April 8, 2011 D View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us